Search Results - "Lonergan, J Tyler"
-
1
Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus—Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study
Published in Clinical infectious diseases (15-01-2004)“…Stavudine use is a contributing factor for lipoatrophy, whereas use of abacavir or zidovudine is less likely to cause this complication. The TARHEEL study was…”
Get full text
Journal Article -
2
Mitochondrial Dysfunction: Patient Monitoring and Toxicity Management
Published in Journal of acquired immune deficiency syndromes (1999) (01-09-2004)“…Mitochondrial toxicity has been implicated in the development of a variety of nucleoside reverse transcriptase inhibitor–associated syndromes. Mitochondrial…”
Get full text
Journal Article Conference Proceeding -
3
COVID-19 Telemedicine and Vaccination at an Urban Safety Net HIV Medicine Clinic
Published in Journal for nurse practitioners (01-09-2022)“…In response to the emerging coronavirus disease 2019 (COVID-19) pandemic in March 2020, the Owen Clinic at UC San Diego Health scaled up telemedicine to ensure…”
Get full text
Journal Article -
4
Lack of Recurrence of Hyperlactatemia in HIV-Infected Patients Switched From Stavudine to Abacavir or Zidovudine
Published in Journal of acquired immune deficiency syndromes (1999) (01-08-2004)“…Stavudine (d4T) has been observed in clinical trials and cohort studies to be more often implicated in cases of hyperlactatemia than other nucleoside reverse…”
Get full text
Journal Article -
5
Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine
Published in AIDS (London) (03-01-2005)“…To determine if stavudine (alpha4T)-associated mitochondrial toxicity could be reversed by substitution with another nucleoside reverse transcriptase…”
Get full text
Journal Article -
6
Hyperlactatemia and Hepatic Abnormalities in 10 Human Immunodeficiency Virus-Infected Patients Receiving Nucleoside Analogue Combination Regimens
Published in Clinical infectious diseases (01-07-2000)“…During a 6-and-a-half month period, we identified 10 human immunodeficiency virus (HIV)-infected men who were receiving antiretroviral regimens, including…”
Get full text
Journal Article -
7
Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected]
Published in Clinical infectious diseases (01-09-2003)“…Pancreatitis occurs in up to 7% of patients infected with human immunodeficiency virus who are treated with standard doses of didanosine. Tenofovir disoproxil…”
Get full text
Journal Article -
8
HIV-associated neuromuscular weakness syndrome
Published in AIDS (London) (02-07-2004)“…To investigate progressive, severe neuromuscular weakness associated with lactic acidosis in some HIV-infected patients after exposure to nucleoside reverse…”
Get full text
Journal Article -
9
Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis
Published in AIDS (London) (21-11-2003)“…To evaluate the safety and efficacy of rechallenging patients who have recovered from nucleoside reverse transcriptase inhibitor (NRTI)-induced symptomatic…”
Get full text
Journal Article -
10
Pancreatitis Treated with Didanosine and Tenofovir Disoproxil Fumarate
Published in Clinical infectious diseases (01-09-2003)“…Pancreatitis occurs in up to 7% of patients infected with human immunodeficiency virus who are treated with standard doses of didanosine. Tenofovir disoproxil…”
Get full text
Journal Article -
11
-
12
-
13
HIV-associated neuromuscular weakness syndrome
Published in AIDS (London) (20-08-2004)Get full text
Journal Article